RESTRUCTURING AND EXIT ACTIVITIES COSTS (Tables)

3 Months Ended

Mar. 31, 2026

These charges are reflected in the following captions in the accompanying Condensed Consolidated Statements of Operations as follows:


	Three Months Ended
(in thousands)	March 31, 2026		March 31, 2025
Cost of sales	$	—	$	163
Selling, general, and administrative expenses	88		558
Research and development	159		276
Total	$	247	$	997

Restructuring and other related charges recorded in cost of sales by reportable segment for the three months ended March 31, 2025 were as follows:

The activity in the restructuring accrual related to the 2025 Restructuring Plan was as follows:


	Three Months Ended
(in thousands)	March 31, 2026		March 31, 2025
Balance at beginning of period	$	1,230	$	—
Costs incurred and other adjustments to accrued liability during the period	247		997
Amounts settled with cash	(1,286)		(399)
Balance at the end of period	$	191	$	598